No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate

byKathleen Lau

January 15, 2021

in StudyGraphics

#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate

O and Rh– blood groups may be associated with decreased risk for SARS-CoV-2 infection

RelatedReports

A woman looks thoughtfully at a computer screen displaying abstract representations of lab test results and confusion related to patient portals.

2 Minute Medicine

Most routine blood tests do not require prolonged fasting

October 9, 2026

A liver illustration with spilled sugar cubes and two drink cups, highlighting the link between sugary drinks and liver health.

Chronic Disease

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

October 7, 2026

An illustration featuring a stomach, DNA helix, and a close-up of Helicobacter pylori bacteria, highlighting genetic susceptibility to gastric conditions.

Artificial Intelligence

Artificial intelligence capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

October 16, 2026

A collage illustrating the urinary bladder, immune system elements, cancer cells, and an IV bag, highlighting immunotherapy for urothelial cancer.

Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Convalescent plasma may not improve outcomes in Covid-19 patients

SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

Hydroxychloroquine may not prevent Covid-19 after contact exposure

#VisualAbstract: Every-other-day dosing of oral rimegepant is effective for preventive treatment of migraines

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate

Most routine blood tests do not require prolonged fasting

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

O and Rh– blood groups may be associated with decreased risk for SARS-CoV-2 infection

Convalescent plasma may not improve outcomes in Covid-19 patients

RelatedReports

Most routine blood tests do not require prolonged fasting

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

Artificial intelligence capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Convalescent plasma may not improve outcomes in Covid-19 patients

Hydroxychloroquine may not prevent Covid-19 after contact exposure

#VisualAbstract: Every-other-day dosing of oral rimegepant is effective for preventive treatment of migraines

2MM+ All Access

Look up any US clinician

Recent Reports

Keep reading with 2 Minute Medicine+

Keep reading with 2 Minute Medicine+

The medical literature, distilled daily.

Membership benefits

#VisualAbstract AMLSG 09-09: Adding getuzumab ozogamicin (GO) to intensive therapy for Nucleophosmin1 mutated acute myeloid leukemia (NPM1mut AML) leads to better NPM1mut transcript clearance and a lower replase rate

RELATED REPORTS

O and Rh– blood groups may be associated with decreased risk for SARS-CoV-2 infection

Convalescent plasma may not improve outcomes in Covid-19 patients

RelatedReports

2MM+ All Access

Look up any US clinician

Recent Reports

Keep reading with 2 Minute Medicine+

Keep reading with 2 Minute Medicine+

The medical literature, distilled daily.

Membership benefits